In addition to highlighting three new biotech companies to watch – all of which are life sciences companies and include recent Nasdaq IPOs – today’s article also highlights new stocks […]
read more
Significant Upside Potential (And Dividends) Make These 3 Biotech Stocks To Watch
“The best biotech companies offer a nice balance between several established drugs bringing the company consistent income along with a robust pipeline of potential blockbuster drugs. However, investing in emerging […]
read more
Penny Stocks To Watch: 4 Under $2.50
Regarding penny stocks, the author of today’s article notes that “These have become some of the hottest topics in the stock market today. Whether it’s discussions about reopening or the […]
read more
Blocking Cancer’s “Cloaking Signal” Creates A Massive Opportunity For This Biotech
With two innovative cancer treatment candidates that seek to block the “cloaking signal” used by cancer cells to trick the immune system into not attacking them, the small biotech highlighted […]
read more
3 Stocks To Play Biotech’s Continued Outperformance In 2021
When it comes to biotech in 2021, the author of today’s article expects the sector to remain very attractive, noting that “Valuations are quite reasonable and earnings have steadily increased. […]
read more
Is The Small-Cap “Submarine” Preparing To Rise?
“If tech has been a rocket, small-caps have been a submarine,” analogize analysts at Jefferies, noting that “With the exception of the post-corporate tax reform run, and a few other […]
read more
2 Pharma Stocks To Consider Picking Up On The Dip
“We all love to buy pharma stocks when they release positive clinical data, but they can also be solid choices for investors looking for businesses to buy on the dip,” […]
read more
Assessing The Best Biotech ETFs
While the biotech sector has outperformed the broader market over the past 12 months, investing in this sector can be risky. As such, the author of today’s article recommends gaining […]
read more
2 Stocks Where Analysts See Strong Gains Ahead
Today’s article details two stocks that, according to both analysts at JPMorgan as well as the broader Wall Street analyst consensus, are primed for strong gains in the weeks and […]
read more
A Mystery Investor’s Massive Post-Election Bet
It appears that a mystery investor has recently spent more than $300 million buying up tens of thousands of S&P 500 call spreads that expire in the days following the […]
read more